Viridian Therapeutics, Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).www.viridiantherapeutics.com
0
MENTIONS
0
EPISODES
0
PODCASTS
Search complete. 0 mentions across 0 episodes found for "Viridian Therapeutics, Inc.".
No mentions of “Viridian Therapeutics, Inc.”
Nothing in this time range.
Or search every podcast